Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01243190
What this trial is testing

Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 44
Early research (Phase 1)Looking for participantsNCT03113643
What this trial is testing

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeBlastic Plasmacytoid Dendritic Cell Neoplasm
Dana-Farber Cancer Institute 72
Testing effectiveness (Phase 2)Study completedNCT00794820
What this trial is testing

Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT01546038
What this trial is testing

Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia
Pfizer 255
Early research (Phase 1)Active Not RecruitingNCT03328273
What this trial is testing

AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Acerta Pharma BV 12
Not applicableStudy completedNCT02101983
What this trial is testing

Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
University of Rochester 11
Testing effectiveness (Phase 2)Study completedNCT02723994
What this trial is testing

Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Incyte Corporation 171
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06598969
What this trial is testing

TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesMyeloid Leukemia, Acute
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 58
Testing effectiveness (Phase 2)Study completedNCT00400673
What this trial is testing

A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Northern Italy Leukemia Group 581
Testing effectiveness (Phase 2)Ended earlyNCT01204788
What this trial is testing

Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 5
Early research (Phase 1)Study completedNCT02920541
What this trial is testing

Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukaemia (AML)Myelodysplastic Syndrome (MDS)
Institut de Recherches Internationales Servier 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05038592
What this trial is testing

Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+1 more
M.D. Anderson Cancer Center 64
Not applicableAvailableNCT01881334
What this trial is testing

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Who this might be right for
Hematologic MalignanciesInborn Errors of Metabolism DisordersImmune Deficiencies
Joanne Kurtzberg, MD
Testing effectiveness (Phase 2)Study completedNCT02217163
What this trial is testing

Carfilzomib, Cyclophosphamide, Dexamethasone in Transplant Eligible Newly Diagnosed High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Singapore General Hospital 30
Not applicableUnknownNCT06072287
What this trial is testing

The Living With a Long-Term Condition Study

Who this might be right for
AsthmaAtrial FibrillationCancer+42 more
King's College London 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT03674411
What this trial is testing

Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaBiphenotypic/Undifferentiated Leukemia+8 more
Masonic Cancer Center, University of Minnesota 22
Early research (Phase 1)Study completedNCT00101296
What this trial is testing

Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Erythroid Leukemia (M6)Adult Acute Megakaryoblastic Leukemia (M7)+16 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT01324063
What this trial is testing

Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 160
Early research (Phase 1)Study completedNCT02078609
What this trial is testing

A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
AML and High Risk MDS
Novartis Pharmaceuticals 70
Very early researchActive Not RecruitingNCT02603887
What this trial is testing

Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 20
Next Page